On its third quarter of 2026 earnings call, held on Oct. 21, 2026, Abbott (ABT -1.89%) announced its plan to spin off its nutrition business into an independent public company. Shedding consumer nutrition sharpens focus on higher-margin medical technologies and diagnostics. The move leaves behind an enterprise with faster underlying sales expansion. Three takeaways from the call stand out. 3. Pulsed Field Ablation Powers Electrophysiology Expansion New catheter technology and expanding regulatory approvals ...

Key Takeaways Abbott's Q3 adjusted EPS missed estimates by 0.7%, while sales rose 14.5% to $13.01 billion.Abbott's Medical Devices and Diagnostics posted growth, while Nutrition sales rose 4.9% on a comparable basis.Abbott expanded gross and operating margins but lowered its 2026 comparable sales growth outlook to 6%.Abbott (ABT) reported third-quarter 2026 adjusted earnings per share of $1.42, up 9.2% year over year. The figure missed the Zacks Consensus Estimate by 0.7%.Sales increased 14.5% year over yea ...

Abbott Laboratories (NYSE:ABT) Q3 2026 Earnings call October 21, 2026 09:00 AM ET Company ParticipantsMike Comilla - VP of Investor RelationsRobert Ford - Chairman and CEOPhil Boudreau - EVP of Finance and CFOConference Call ParticipantsRobert Marcus - AnalystLarry Biegelsen - AnalystPatrick Wood - AnalystMatt Taylor - AnalystVijay Kumar - AnalystTravis Steed - AnalystJoanne Wuensch - AnalystOperatorGood morning, and thank you for standing by. Welcome to Abbott's Third Quarter 2026 Earnings Conference Call. ...

Abbott Laboratories (NYSE:ABT) Q3 2026 Earnings call October 21, 2026 09:00 AM ET Speaker0Good morning, and thank you for standing by. Welcome to Abbott's third quarter 2026 earnings conference call. All participants will be able to listen only until the question and answer portion of this call. During the question and answer session, you will be able to ask your question by pressing the star 11 keys on your touchtone phone. This call is being recorded by Abbott. With the exception of any participant's ques ...

Abbott Reports Third-Quarter 2026 Results and Reaffirms Full-Year EPS Guidance Abbott Reports Third-Quarter 2026 Results and Reaffirms Full-Year EPS Guidance Abbott Oct 21, 2026, 07:30 ET ABBOTT PARK, Ill., Oct. 21, 2026 /PRNewswire/ -- Abbott (NYSE: ABT) today announced financial results for the third quarter ended Sept. 30, 2026. "Abbott delivered strong third-quarter results, reflecting balanced growth across our portfolio," said Robert B. Ford, chairman and chief executive officer, Abbott. "With strong ...